Clonazepam in childhood anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, March, 1994 by Klein, Rachel G.

There is ample literature from controlled studies to support the benefit of benzodiazepines in adult anxiety disorders. In the cross-national collaborative panic study (Ballenger et al., 1988), for example, alprazolam (5 mg/day) was found superior to placebo in adults with panic disorder or agoraphobia.

Controlled studies of Rickels et al. (1983), Pollack et al. (1986), and Tesar et al. (1987) found similar responses for alprazolam (2 to 3 mg/day), diazepam (30 to 40 mg/day), and clonazepam (CZP; 2 to 3 mg/day) in adults with a variety of anxiety disorders. The literature on the ...